Radiopharmaceuticals supply (SRH, RSCH & PRH)

University Hospitals Sussex NHS Foundation Trust recently completed a procurement process titled "Radiopharmaceuticals supply (SRH, RSCH & PRH)" in the nuclear medicine sector. This procurement, published on 27th October 2025, involves the supply of radiopharmaceuticals crucial for medical imaging. The process has reached the Award stage with the contract start date set for 4th November 2025, and a possible extension until 31st March 2027.

Direct award procurement was utilised due to geographic suitability considerations, with the supply distributed across several UK regions, including Worthing, Southampton, and Gillingham. The total gross value of the contracts amounts to £1,176,141, highlighting substantial opportunities within central government procurement. This procurement offers significant growth opportunities for businesses within the nuclear medicine and medical laboratory sectors.

Companies specialising in radiopharmaceuticals and related medical supplies could find lucrative prospects, particularly those with established capabilities in direct supply and regional distribution. Large-scale enterprises, like University Hospital Southampton NHS Foundation Trust and Medway NHS Foundation Trust, have succeeded in securing contracts, indicating the potential for business expansion by adapting to the supply dynamics of NHS facilities. Businesses poised to deliver innovative and responsive logistics for critical medical supplies are well-suited to engage in similar future opportunities.